Collegium Pharmaceutical, Inc. (COLL)
24.72
+0.51
(+2.11%)
USD |
NASDAQ |
Nov 09, 09:59
Collegium Pharmaceutical Price to Book Value : 2.591 for Nov. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 2.538 |
| November 05, 2026 | 2.637 |
| November 04, 2026 | 2.481 |
| November 03, 2026 | 2.487 |
| November 02, 2026 | 2.482 |
| October 30, 2026 | 2.495 |
| October 29, 2026 | 2.519 |
| October 28, 2026 | 2.435 |
| October 27, 2026 | 2.411 |
| October 26, 2026 | 2.433 |
| October 23, 2026 | 2.407 |
| October 22, 2026 | 2.463 |
| October 21, 2026 | 2.402 |
| October 20, 2026 | 2.435 |
| October 19, 2026 | 2.412 |
| October 16, 2026 | 2.431 |
| October 15, 2026 | 2.430 |
| October 14, 2026 | 2.359 |
| October 13, 2026 | 2.257 |
| October 12, 2026 | 2.311 |
| October 09, 2026 | 2.315 |
| October 08, 2026 | 2.318 |
| October 07, 2026 | 2.299 |
| October 06, 2026 | 2.293 |
| October 05, 2026 | 2.292 |
| Date | Value |
|---|---|
| October 02, 2026 | 2.308 |
| October 01, 2026 | 2.289 |
| September 30, 2026 | 2.287 |
| September 29, 2026 | 2.316 |
| September 28, 2026 | 2.358 |
| September 25, 2026 | 2.347 |
| September 24, 2026 | 2.359 |
| September 23, 2026 | 2.339 |
| September 22, 2026 | 2.374 |
| September 21, 2026 | 2.401 |
| September 18, 2026 | 2.372 |
| September 17, 2026 | 2.332 |
| September 16, 2026 | 2.312 |
| September 15, 2026 | 2.276 |
| September 14, 2026 | 2.377 |
| September 11, 2026 | 2.370 |
| September 10, 2026 | 2.388 |
| September 09, 2026 | 2.434 |
| September 08, 2026 | 2.435 |
| September 04, 2026 | 2.452 |
| September 03, 2026 | 2.469 |
| September 02, 2026 | 2.532 |
| September 01, 2026 | 2.501 |
| August 31, 2026 | 2.564 |
| August 28, 2026 | 2.641 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.426 |
| Corcept Therapeutics, Inc. | 9.464 |
| Veru, Inc. | 1.316 |
| Johnson & Johnson | 8.200 |
| Eli Lilly & Co. | 32.54 |
Price to Book Value Related Metrics
| PE Ratio | 24.93 |
| PS Ratio | 1.150 |
| Price to Free Cash Flow | 2.788 |
| Price | 24.72 |
| Earnings Yield | 4.01% |
| Market Cap | 803.36M |
| Operating PE Ratio | 7.456 |
| Normalized PE Ratio | 18.89 |